Exploring the Pharmacogenomics Knowledge Base (PharmGKB) for Repositioning Breast Cancer Drugs by Leveraging Web Ontology Language (OWL) and Cheminformatics Approaches

Computational drug repositioning leverages computational technology and high volume of biomedical data to identify new indications for existing drugs. Since it does not require costly experiments that have a high risk of failure, it has attracted increasing interest from diverse fields such as biomedical, pharmaceutical, and informatics areas. In this study, we used pharmacogenomics data generated from pharmacogenomics studies, applied informatics and Semantic Web technologies to address the drug repositioning problem. Specifically, we explored PharmGKB to identify pharmacogenomics related associations as pharmacogenomics profiles for US Food and Drug Administration (FDA) approved breast cancer drugs. We then converted and represented these profiles in Semantic Web notations, which support automated semantic inference. We successfully evaluated the performance and efficacy of the breast cancer drug pharmacogenomics profiles by case studies. Our results demonstrate that combination of pharmacogenomics data and Semantic Web technology/Cheminformatics approaches yields better performance of new indication and possible adverse effects prediction for breast cancer drugs.

[1]  Darko Butina,et al.  Unsupervised Data Base Clustering Based on Daylight's Fingerprint and Tanimoto Similarity: A Fast and Automated Way To Cluster Small and Large Data Sets , 1999, J. Chem. Inf. Comput. Sci..

[2]  David B. Searls,et al.  Data integration: challenges for drug discovery , 2005, Nature Reviews Drug Discovery.

[3]  N. Null.  The IUPAC International Chemical Identifier (InChI) , 2009 .

[4]  T I Oprea,et al.  Cheminformatics: a tool for decision-makers in drug discovery. , 2001, Current opinion in drug discovery & development.

[5]  I. Gutman,et al.  Simplified molecular input line entry system (SMILES) as an alternative for constructing quantitative structure-property relationships (QSPR) , 2005 .

[6]  Yan Zhao,et al.  Drug repositioning: a machine-learning approach through data integration , 2013, Journal of Cheminformatics.

[7]  Michel Dumontier,et al.  Towards pharmacogenomics knowledge discovery with the semantic web , 2009, Briefings Bioinform..

[8]  Egon L. Willighagen,et al.  The Chemistry Development Kit (CDK): An Open-Source Java Library for Chemo-and Bioinformatics , 2003, J. Chem. Inf. Comput. Sci..

[9]  Zhiyong Lu,et al.  A new method for computational drug repositioning using drug pairwise similarity , 2012, 2012 IEEE International Conference on Bioinformatics and Biomedicine.

[10]  Vanita Suri,et al.  Tamoxifen: An alternative to clomiphene in women with polycystic ovary syndrome , 2011, Journal of human reproductive sciences.

[11]  Russ B. Altman,et al.  PharmGKB: the Pharmacogenetics Knowledge Base , 2002, Nucleic Acids Res..

[12]  Alexander A. Morgan,et al.  Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data , 2011, Science Translational Medicine.

[13]  Alexander A. Morgan,et al.  Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease , 2011, Science Translational Medicine.

[14]  Sean Bechhofer,et al.  OWL: Web Ontology Language , 2009, Encyclopedia of Database Systems.

[15]  Zhiwei Cao,et al.  A pathway profile-based method for drug repositioning , 2012 .

[16]  Christopher G. Chute,et al.  Using Semantic Web Technologies for Cohort Identification from Electronic Health Records for Clinical Research , 2012, AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science.

[17]  Nigel Shadbolt,et al.  Resource Description Framework (RDF) , 2009 .

[18]  Seong-Hoon Park,et al.  Effect of combined treatment with progesterone and tamoxifen on the growth and apoptosis of human ovarian cancer cells. , 2011, Oncology reports.